Dr. Ginsburg Addresses Global Disparities in Cervical Cancer

Ophira Ginsburg, MD
Published: Thursday, Apr 19, 2018



Ophira Ginsburg, MD, director of the High Risk/Cancer Genetics Program at NYU Langone's Perlmutter Cancer Center, addresses global disparities in cervical cancer.

Until now, many countries have been understandably reluctant to allocating resources toward cancer, as it has historically been seen as an expensive disease to treat, and almost impossible to prevent, says Ginsburg.

There are many opportunities to tackle cervical cancer control in low- and middle-income countries that may not be obvious, says Ginsburg. The first option is to improve the health system for cancer care more broadly, such as teaching the importance of radiotherapy and brachytherapy. It is important to include these technologies, infrastructures, resources, and training in order to address the cancer burden as a whole in these countries. Once that is done, preventing or treating a disease such as cervical cancer, which is relatively well controlled in the first-world, will be an easier task.
SELECTED
LANGUAGE


Ophira Ginsburg, MD, director of the High Risk/Cancer Genetics Program at NYU Langone's Perlmutter Cancer Center, addresses global disparities in cervical cancer.

Until now, many countries have been understandably reluctant to allocating resources toward cancer, as it has historically been seen as an expensive disease to treat, and almost impossible to prevent, says Ginsburg.

There are many opportunities to tackle cervical cancer control in low- and middle-income countries that may not be obvious, says Ginsburg. The first option is to improve the health system for cancer care more broadly, such as teaching the importance of radiotherapy and brachytherapy. It is important to include these technologies, infrastructures, resources, and training in order to address the cancer burden as a whole in these countries. Once that is done, preventing or treating a disease such as cervical cancer, which is relatively well controlled in the first-world, will be an easier task.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Consultations® in Ovarian Cancer: Differentiating Among Clinical Trial Designs to Match PARP to PatientOct 31, 20191.5
Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Lung Cancer, Genitourinary Malignancies, and Gynecologic MalignanciesDec 30, 20192.25
Publication Bottom Border
Border Publication
x